HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Cerebral Perfusion Pressure

Cerebral Perfusion Pressure

Cerebral perfusion pressure (CPP) is a critical value for determining neurological health and determining the effects of treatments used to treat increased ICP (Intracranial Pressure). It is the pressure gradient between the Arterial and Venous systems in the brain, and is generally maintained between 60 and 130 mmHg. In most cases, CPP is calculated using the MAP (mean arterial pressure) minus the ICP (intracranial pressure). However, other factors such as intracranial blood volume, intracranial compliance, and ventricular compliance can also affect CPP. Normal CPP helps to meet the brain’s metabolic needs by guaranteeing that the brain has enough oxygen, glucose, and other nutrients to function properly. If the CPP rises above or falls below the normal range, the brain cannot receive an adequate supply of these nutrients and may cause severe neurological damage. CPP can be increased by increasing MAP or decreasing ICP, which can be achieved by different interventions. These include using medications to reduce ICP, applying an external pressure to the head, or using a shunt system to drain out excess CSF (cerebral spinal fluid). CPP can also be lowered by increasing ICP further or decreasing MAP, which can be done surgically. In certain severe cases, a decrease in CPP can be fatal. However, an increase in CPP can be beneficial in reducing the risk of ischemia, increasing oxygen delivery, preventing hypoxia, and reducing intracranial edema. It is important to monitor CPP in order to provide the best care to a patient. CPP measurement can be done using invasive or non-invasive methods. Invasive methods include measuring around an invasive arterial catheter or ventricular catheter, while non-invasive methods can be done using cerebral autoregulation or ultrasound technology.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States
Tags

Submit your abstract Today

Watsapp